atorvastatin
Showing 26 - 50 of 462
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Non ST Segment Elevation Acute Coronary Syndrome Trial in Pescia, Pistoia, Prato (Colchicine, Atorvastatin)
Recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- Colchicine
- Atorvastatin
-
Pescia, Italy
- +2 more
Mar 1, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Durham (Atorvastatin (40 mg daily), Placebo)
Not yet recruiting
- NASH - Nonalcoholic Steatohepatitis
- Atorvastatin
- Placebo
-
Rochester, Minnesota
- +1 more
Dec 21, 2022
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
- Atorvastatin
- Capecitabine
-
Gilbert, Arizona
- +4 more
Dec 6, 2022
Extra Alirocumab in Addition to Statin Therapy in Symptomatic
Recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis
- Alirocumab
- Atorvastatin
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Sep 24, 2023
Stable Coronary Artery Disease Trial in Pavia (Atorvastatin)
Terminated
- Stable Coronary Artery Disease
- Atorvastatin
-
Pavia, ItalyFondazione Irccs Policlinico San Matteo
Aug 30, 2021
Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)
Not yet recruiting
- Intracranial Atherosclerosis
- +2 more
- Alirocumab
- Atorvastatin
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Oct 10, 2023
Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)
Not yet recruiting
- Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
- Evolocumab
- Atorvastatin
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Feb 14, 2023
Hypertension, Hyperlipidemias Trial in New Haven (Atorvastatin, )
Withdrawn
- Hypertension
- Hyperlipidemias
- Atorvastatin
- placebo
-
New Haven, ConnecticutYale School of Medicine
Oct 31, 2022
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
NASH - Nonalcoholic Steatohepatitis Trial in Herston, Adelaide (ALT-801, Metformin, Atorvastatin)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- ALT-801
- +5 more
-
Herston, Queensland, Australia
- +1 more
Nov 8, 2021
Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)
Completed
- Thyroid Associated Ophthalmopathy
- Hypercholesterolemia
- Atorvastatin
- Methylprednisolone
-
Pisa, ItalyOspedale Cisanello-Endocrinology I and II
Aug 12, 2021
Osteoporosis, Hypercholesterolemia Trial (Atorvastatin)
Completed
- Osteoporosis
- Hypercholesterolemia
- Atorvastatin
- (no location specified)
Apr 30, 2021
Hypercholesterolemia Trial in Miami (Atorvastatin)
Completed
- Hypercholesterolemia
- Atorvastatin
-
Miami, FloridaPfizer Investigational Site
Feb 17, 2021
Endometriosis Trial in University Park (Atorvastatin)
Recruiting
- Endometriosis
- Atorvastatin
-
University Park, PennsylvaniaThe Pennsylvania State University
Apr 8, 2022
Hypercholesterolemia Trial in Miami (Atorvastatin)
Completed
- Hypercholesterolemia
- Atorvastatin
-
Miami, FloridaPfizer Investigational Site
Feb 17, 2021
Sleep Apnea, Obstructive Trial in Rochester (Atorvastatin, Placebo oral capsule)
Enrolling by invitation
- Sleep Apnea, Obstructive
- Atorvastatin
- Placebo oral capsule
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 4, 2022
COVID-19 Trial in Cambridge (Atorvastatin)
Recruiting
- COVID-19
- Atorvastatin
-
Cambridge, MassachusettsMount Auburn Hospital
Mar 17, 2021
Hypercholesterolemia Trial in New Haven (Atorvastatin, Atorvastatin pediatric appropriate formulation)
Completed
- Hypercholesterolemia
- Atorvastatin
- Atorvastatin pediatric appropriate formulation
-
New Haven, ConnecticutPfizer Investigational Site
Feb 17, 2021
Pediatric Heterozygous Hypercholesterolemia Trial in Quebec, Athens, Oslo (Atorvastatin)
Completed
- Pediatric Heterozygous Hypercholesterolemia
- Atorvastatin
-
Quebec, Canada
- +2 more
Feb 17, 2021
Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- Myelodysplastic Syndromes
- Atorvastatin
- Rosuvastatin
-
Saint Louis, MissouriWashington University School of Medicine
Jul 28, 2022
Dyslipidemias Trial in Bangkok, Chiang Mai (Atorvastatin)
Completed
- Dyslipidemias
- Atorvastatin
-
Bangkok, Thailand
- +3 more
Feb 17, 2021
Hyperlipidemias Trial in Taiwan (atorvastatin)
Completed
- Hyperlipidemias
- atorvastatin
-
Kaohsiung Hsien, Taiwan
- +4 more
Feb 17, 2021